262 related articles for article (PubMed ID: 32223926)
1. Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING.
Li YN; Su Y
Biochem Biophys Res Commun; 2020 May; 526(2):381-388. PubMed ID: 32223926
[TBL] [Abstract][Full Text] [Related]
2. Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease.
Qiao JT; Cui C; Qing L; Wang LS; He TY; Yan F; Liu FQ; Shen YH; Hou XG; Chen L
Metabolism; 2018 Apr; 81():13-24. PubMed ID: 29106945
[TBL] [Abstract][Full Text] [Related]
3. Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling.
Liang L; Ye S; Jiang R; Zhou X; Zhou J; Meng S
Int Immunopharmacol; 2022 Mar; 104():108306. PubMed ID: 34999396
[TBL] [Abstract][Full Text] [Related]
4. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
Wu L; Liu Y; Zhao Y; Li M; Guo L
Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
[TBL] [Abstract][Full Text] [Related]
5. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.
Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C
Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555
[TBL] [Abstract][Full Text] [Related]
6. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
7. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
Pan ZG; An XS
Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
[TBL] [Abstract][Full Text] [Related]
8. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.
Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF
Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632
[TBL] [Abstract][Full Text] [Related]
9. Juglanin protects against high fat diet-induced renal injury by suppressing inflammation and dyslipidemia via regulating NF-κB/HDAC3 signaling.
Li Q; Ge C; Tan J; Sun Y; Kuang Q; Dai X; Zhong S; Yi C; Hu LF; Lou DS; Xu M
Int Immunopharmacol; 2021 Jun; 95():107340. PubMed ID: 33667999
[TBL] [Abstract][Full Text] [Related]
10. Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice.
Hao YR; Tang FJ; Zhang X; Wang H
Biochem Biophys Res Commun; 2018 Sep; 503(2):564-571. PubMed ID: 29852170
[TBL] [Abstract][Full Text] [Related]
11. Sodium fluorocitrate having inhibitory effect on fatty acid uptake ameliorates high fat diet-induced non-alcoholic fatty liver disease in C57BL/6J mice.
Hong SA; Jung IR; Choi SE; Hwang Y; Lee SJ; Son Y; Heo YJ; Cui R; Han SJ; Kim HJ; Lee KW; Kang Y
Sci Rep; 2019 Nov; 9(1):17839. PubMed ID: 31780766
[TBL] [Abstract][Full Text] [Related]
12. Effects of XIAP on high fat diet-induced hepatic steatosis: a mechanism involving NLRP3 inflammasome and oxidative stress.
Zilu S; Qian H; Haibin W; Chenxu G; Deshuai L; Qiang L; Linfeng H; Jun T; Minxuan X
Aging (Albany NY); 2019 Dec; 11(24):12177-12201. PubMed ID: 31841118
[TBL] [Abstract][Full Text] [Related]
13. Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages.
Cao L; Xu E; Zheng R; Zhangchen Z; Zhong R; Huang F; Ye J; Sun H; Fan Y; Xie S; Chen Y; Xu Y; Cao J; Cao W; Liu C
Chin Med; 2022 Jan; 17(1):7. PubMed ID: 34983596
[TBL] [Abstract][Full Text] [Related]
14. Ugonin J improves metabolic disorder and ameliorates nonalcoholic fatty liver disease by regulating the AMPK/AKT signaling pathway.
Chang TC; Chiou WC; Lai WH; Huang HC; Huang YL; Liu HK; Liang YC; Huang C
Pharmacol Res; 2021 Jan; 163():105298. PubMed ID: 33220422
[TBL] [Abstract][Full Text] [Related]
15. Suppressing NLRP2 expression accelerates hepatic steatosis: A mechanism involving inflammation and oxidative stress.
Li C; Liu Q; Xie L
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):22-29. PubMed ID: 30454891
[TBL] [Abstract][Full Text] [Related]
16. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress.
Chenxu G; Minxuan X; Yuting Q; Tingting G; Jing F; Jinxiao L; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Xuyuan N; Mingxing W; Ping H; Jun T
Free Radic Biol Med; 2019 Apr; 134():23-41. PubMed ID: 30599260
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane protein 126B protects against high fat diet (HFD)-induced renal injury by suppressing dyslipidemia via inhibition of ROS.
Weihong C; Bin C; Jianfeng Y
Biochem Biophys Res Commun; 2019 Jan; 509(1):40-47. PubMed ID: 30580996
[TBL] [Abstract][Full Text] [Related]
18. Targeting DUSP16/TAK1 signaling alleviates hepatic dyslipidemia and inflammation in high fat diet (HFD)-challenged mice through suppressing JNK MAPK.
Wu YK; Hu LF; Lou DS; Wang BC; Tan J
Biochem Biophys Res Commun; 2020 Mar; 524(1):142-149. PubMed ID: 31982140
[TBL] [Abstract][Full Text] [Related]
19. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
[TBL] [Abstract][Full Text] [Related]
20. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.
Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH
Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
